NXTC
NextCure (NXTC)
$48
About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Details
Daily high
$1.48
Daily low
$1.40
Price at open
$1.43
52 Week High
$2.57
52 Week Low
$0.98
Market cap
39.7M
Dividend yield
0.00%
Volume
11,662
Avg. volume
41,458
P/E ratio
-.65
NextCure News
Details
Daily high
$1.48
Daily low
$1.40
Price at open
$1.43
52 Week High
$2.57
52 Week Low
$0.98
Market cap
39.7M
Dividend yield
0.00%
Volume
11,662
Avg. volume
41,458
P/E ratio
-.65